Lung transplantation for interstitial lung disease

Brandon S. Lu, Sangeeta M. Bhorade

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Lung transplantation has evolved as a definitive therapy for patients with end-stage ILD that is refractory to medical therapy. Early referral of patients with ILD is important to ensure appropriate timing for transplantation. Currently, lung transplantation has been associated with improved lung function, exercise capacity, quality of life, and survival in this group of patients. Donor availability and the long-term complications of infection and rejection after transplantation limit lung transplantation, however. With continued investigation into increasing the donor pool, improving immunosuppressive strategies, determining immune tolerance, and improving surgical techniques, outcomes after lung transplantation will continue to improve.

Original languageEnglish (US)
Pages (from-to)773-782
Number of pages10
JournalClinics in Chest Medicine
Issue number4 SPEC.ISS.
StatePublished - Dec 2004

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Lung transplantation for interstitial lung disease'. Together they form a unique fingerprint.

Cite this